| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 11/06/2012 | US8304200 Methods for obtaining antibodies |
| 11/06/2012 | US8304199 Methods for diagnosing and monitoring the progression of cancer by measuring soluble c-Met ectodomain |
| 11/06/2012 | US8304198 Assay for detection of transient intracellular CA2+ |
| 11/06/2012 | US8304197 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| 11/06/2012 | US8304196 In situ analysis of tissues |
| 11/06/2012 | US8304195 Antibody complexes and methods for immunolabeling |
| 11/06/2012 | US8304194 Quantification of gene expression |
| 11/06/2012 | US8304182 Methods of identifying anti-cancer agents and uses thereof |
| 11/06/2012 | US8303959 Compositions and methods for detection of antibodies specific for Anaplasma phagocytophilum (Aph) and Anaplasma platys (Apl) |
| 11/06/2012 | US8303910 Biosensor |
| 11/06/2012 | US8303909 Microfluidic assembly |
| 11/06/2012 | US8303908 Analyzing tool and device |
| 11/06/2012 | US8303907 Biosensors, and method and kits for using same |
| 11/06/2012 | US8303906 Test element for analyzing body fluids |
| 11/06/2012 | US8303896 Biosensor and method for immobilizing a physiologically active substance |
| 11/06/2012 | US8303801 Method for determining the concentration of an analyte in a liquid sample using small volume samples and fast test times |
| 11/06/2012 | US8303788 Liquid electrolyte gas sensor comprising rigid porous electrode support |
| 11/06/2012 | US8303518 Autonomous, ambulatory analyte monitor or drug delivery device |
| 11/06/2012 | CA2743404C Multi-chambered receptacles |
| 11/06/2012 | CA2611876C Uv transmittance measuring device |
| 11/06/2012 | CA2536688C Method for the in vitro titration of an ncta and application thereof in a method for the evaluation and/or monitoring of a biological product production method |
| 11/06/2012 | CA2501931C Portable spray rack |
| 11/06/2012 | CA2460114C Assay buffer, compositions containing the same, and methods of using the same |
| 11/06/2012 | CA2450939C Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 11/06/2012 | CA2434737C Non aggregating fluorescent proteins and methods for using the same |
| 11/06/2012 | CA2393467C Chordin-like molecules and uses thereof |
| 11/06/2012 | CA2371745C Tire uniformity prediction using balance and low speed uniformity data |
| 11/06/2012 | CA2365533C Diagnosis and treatment of neuroectodermal tumors |
| 11/06/2012 | CA2326724C Mixed cell diagnostic systems |
| 11/06/2012 | CA2288801C A method and a system for determination of particles in a liquid sample |
| 11/01/2012 | WO2012149550A1 Methods of identification and diagnosis of lung diseases using classification systems and kits thereof |
| 11/01/2012 | WO2012149410A2 Methods of collecting and analyzing samples |
| 11/01/2012 | WO2012149351A1 Fecal lactoferrin as a biomarker for determining disease severity and for monitoring infection in patients with clostridium difficile disease |
| 11/01/2012 | WO2012149323A1 Assay for ship1 expression, activity and sequence alterations as a predictor of inflammatory bowel disease risk |
| 11/01/2012 | WO2012149312A1 Time-gated fluorescence imaging with si-containing particles |
| 11/01/2012 | WO2012149310A1 Analysis of pressurized reservoir fluids |
| 11/01/2012 | WO2012149299A2 Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor |
| 11/01/2012 | WO2012149291A1 Analysis of drilling cuttings for permittivity |
| 11/01/2012 | WO2012149285A1 Method for treatment of macular degeneration by modulating p2y12 or p2x7 receptors |
| 11/01/2012 | WO2012149269A2 Determination of cd and/or md variations from scanning measurements of a sheet of material |
| 11/01/2012 | WO2012149246A1 Methods of treating squamous cell carcinoma related applications |
| 11/01/2012 | WO2012149245A2 Genomic signatures of metastasis in prostate cancer |
| 11/01/2012 | WO2012149211A1 Hematology control compositions with extended stability |
| 11/01/2012 | WO2012149188A2 Compositions and methods for detecting and identifying nucleic acid sequences in biological samples |
| 11/01/2012 | WO2012149180A2 Fluorescent tracking dye |
| 11/01/2012 | WO2012149171A1 Designing padlock probes for targeted genomic sequencing |
| 11/01/2012 | WO2012149126A1 Plasma or serum production and removal of fluids under reduced pressure |
| 11/01/2012 | WO2012149076A2 Method and apparatus for determination of system parameters for reducing crude unit corrosion |
| 11/01/2012 | WO2012149006A2 Formation resistivity imager with reduced leakage to mandrel |
| 11/01/2012 | WO2012148797A1 Systems for intravenous drug monitoring |
| 11/01/2012 | WO2012148549A1 Detection of an immune response |
| 11/01/2012 | WO2012148516A2 Bioaffinity sensors based on surface monolayers |
| 11/01/2012 | WO2012148297A1 Method for determining skin sensitisation potential |
| 11/01/2012 | WO2012148230A2 Screening method of therapeutic agent for bipolar disorders |
| 11/01/2012 | WO2012148017A1 Sol-gel kit for manufacturing a biochip and method for manufacturing a biochip by using same |
| 11/01/2012 | WO2012148003A1 ANTI-HUMAN RECEPTOR-TYPE PROTEIN TYROSINE PHOSPHATASE σ ANTIBODY |
| 11/01/2012 | WO2012147992A1 ANTI-iPS/ES CELL-SPECIFIC ANTIBODY AND USE THEREOF |
| 11/01/2012 | WO2012147965A1 Method for making biological material transparent and use thereof |
| 11/01/2012 | WO2012147902A1 Antiarrhythmic drug, atrial fibrillation inhibitor, model of sustained atrial fibrillation and method for producing same, and method for screening atrial fibrillation inhibitor |
| 11/01/2012 | WO2012147798A1 Method for detecting neurological disease associated with cognitive dysfunction by measuring epha4 extracellular domain |
| 11/01/2012 | WO2012147774A1 Method for producing silica nanoparticles containing functional molecules to which biomolecules are bonded |
| 11/01/2012 | WO2012147757A1 Method and kit for determining age-related macular degeneration vulnerability |
| 11/01/2012 | WO2012147670A1 Method for determining prognosis of renal failure |
| 11/01/2012 | WO2012147578A1 Method for classifying/counting leukocytes, reagent kit for classifying leukocytes, and reagent for classifying leukocytes |
| 11/01/2012 | WO2012147492A1 Image processing device, image processing method, image processing program, and virtual microscope system |
| 11/01/2012 | WO2012147451A1 Blood analyzer, blood analysis method, and computer program |
| 11/01/2012 | WO2012147429A1 Glass particles containing enclosed semiconductor nanoparticles, and process for producing glass particles containing enclosed semiconductor nanoparticles |
| 11/01/2012 | WO2012147078A1 A system and a method for detecting abnormal occurrences |
| 11/01/2012 | WO2012147000A1 Sensor system with an exchangeable cartridge and a reader |
| 11/01/2012 | WO2012146919A1 Cxcr1 as a predictor of response to treatment with epidermal growth factor receptor therapeutic |
| 11/01/2012 | WO2012146913A1 Automatic gemstone orientation |
| 11/01/2012 | WO2012146841A1 Accelerometer-controlled positive-drive device and method for the non-destructive measurement of firmness |
| 11/01/2012 | WO2012146778A2 Method for indicating a renal disease in a patient |
| 11/01/2012 | WO2012146776A1 Test systems and methods for identifying and characterising lipid lowering drugs |
| 11/01/2012 | WO2012146729A1 Lasso peptides as scaffolds for peptide grafting |
| 11/01/2012 | WO2012146723A1 Sflt-1 and troponin t as biomarkers of pulmonary embolism |
| 11/01/2012 | WO2012146684A1 Sensor element with a ta or nb containing base layer, and method for the production thereof |
| 11/01/2012 | WO2012146645A1 Diagnosis of kidney injury after surgery |
| 11/01/2012 | WO2012146585A1 Test systems and methods for identifying a compound altering cellular ddr activity |
| 11/01/2012 | WO2012146497A1 In vitro method for determining developmental toxicity of a compound |
| 11/01/2012 | WO2012146496A1 Method for determining the neurodevelopmental toxicity of a compound in vitro |
| 11/01/2012 | WO2012146453A1 Integrated field-effect gas sensor with means for ascertaining a variable for determining the work function and change of mass of a gas sensor material |
| 11/01/2012 | WO2012146420A1 Gas sensor device comprising a protective cap having protective elements against liquids |
| 11/01/2012 | WO2012146417A1 Sensor apparatus for detecting a parameter of a flowing fluid medium |
| 11/01/2012 | WO2012146116A1 An assay device for testing an analyte in samples |
| 11/01/2012 | WO2012145925A1 Uses of food allergens and antibodies thereof in iga nephropathy |
| 11/01/2012 | WO2012145794A1 Method of determining response to treatment with immunomodulatory composition |
| 11/01/2012 | WO2012145786A1 An assay of cell mediated immune responsiveness |
| 11/01/2012 | WO2012125220A3 Methods for isolation, identification, and quantification of mirnas |
| 11/01/2012 | WO2012122359A3 Target directed to adipocytes, methods and assays for treatment of obesity |
| 11/01/2012 | WO2012122228A3 Biomarkers of chronic obstructive pulmonary disease |
| 11/01/2012 | WO2012121746A3 Imaging beta cell mass |
| 11/01/2012 | WO2012118928A3 Glycoprofiling with multiplexed suspension arrays |
| 11/01/2012 | WO2012118806A3 Compositions and methods for detecting and treating cancer |
| 11/01/2012 | WO2012114312A3 Exogenous internal positive control |
| 11/01/2012 | WO2012106291A3 Systems and methods for determining alumina properties |
| 11/01/2012 | WO2012106081A3 Methods for reducing nucleic acid damage |
| 11/01/2012 | WO2012104620A3 Wound prognosis |
| 11/01/2012 | WO2012103479A3 Gas sorption analysis of unconventional rock samples |
| 11/01/2012 | WO2012103324A3 Method for detection of intestinal, and blood-brain barrier permeability and testing materials thereto |